While Amneal Pharmaceuticals Inc has overperformed by 1.04%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMRX rose by 46.97%, with highs and lows ranging from $12.12 to $6.68, whereas the simple moving average jumped by 34.03% in the last 200 days.
On June 06, 2025, Goldman started tracking Amneal Pharmaceuticals Inc (NASDAQ: AMRX) recommending Buy. A report published by JP Morgan on February 24, 2025, Upgraded its rating to ‘Overweight’ for AMRX. JP Morgan also Upgraded AMRX shares as ‘Neutral’, setting a target price of $9 on the company’s shares in a report dated September 06, 2024. RBC Capital Mkts Initiated an Sector Perform rating on April 07, 2021, and assigned a price target of $5. Goldman March 08, 2021d its ‘Sell’ rating to ‘Buy’ for AMRX, as published in its report on March 08, 2021. Guggenheim’s report from December 14, 2020 suggests a price prediction of $5.50 for AMRX shares, giving the stock a ‘Buy’ rating. Barclays also rated the stock as ‘Overweight’.
Analysis of Amneal Pharmaceuticals Inc (AMRX)
Further, the quarter-over-quarter increase in sales is 11.68%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Amneal Pharmaceuticals Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -155.38% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.42, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.69M can be a very valuable indicator of volatility for AMRX stock. On a monthly basis, the volatility of the stock is set at 3.59%, whereas on a weekly basis, it is put at 3.27%, with a gain of 2.37% over the past seven days. Furthermore, long-term investors anticipate a median target price of $13.50, showing growth from the present price of $11.64, which can serve as yet another indication of whether AMRX is worth investing in or should be passed over.
How Do You Analyze Amneal Pharmaceuticals Inc Shares?
The USA based company Amneal Pharmaceuticals Inc (AMRX) is one of the biggest names in Drug Manufacturers – Specialty & Generic. When comparing Amneal Pharmaceuticals Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 819.72, there is a growth in quarterly earnings of 1560.00%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 50.19%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 43.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
